These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12119236)

  • 1. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.
    Crystal RG; Bitterman PB; Mossman B; Schwarz MI; Sheppard D; Almasy L; Chapman HA; Friedman SL; King TE; Leinwand LA; Liotta L; Martin GR; Schwartz DA; Schultz GS; Wagner CR; Musson RA
    Am J Respir Crit Care Med; 2002 Jul; 166(2):236-46. PubMed ID: 12119236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic pulmonary fibrosis].
    Doubková M; Skhicková J
    Vnitr Lek; 2005 Dec; 51(12):1375-84. PubMed ID: 16430105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic pulmonary fibrosis: molecular mechanisms and possible therapeutic strategies.
    van den Blink B; Jansen HM; Peppelenbosch MP
    Arch Immunol Ther Exp (Warsz); 2000; 48(6):539-45. PubMed ID: 11197609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
    Maher TM; Wells AU; Laurent GJ
    Eur Respir J; 2007 Nov; 30(5):835-9. PubMed ID: 17978154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Idiopathic pulmonary fibrosis: new diagnostic and therapeutic perspectives].
    Alvarez-Sala R; Prados C; Garciá FR; Lázaro TC; García-Satúe JL; Pino JM; Villamor J
    An Med Interna; 1993 Jul; 10(7):355-60. PubMed ID: 8218773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis.
    Agostini C; Gurrieri C
    Proc Am Thorac Soc; 2006 Jun; 3(4):357-63. PubMed ID: 16738201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary fibrosis: current trends in management.
    Raghu G; Chang J
    Clin Chest Med; 2004 Dec; 25(4):621-36, v. PubMed ID: 15564012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical advances in the diagnosis and therapy of the interstitial lung diseases.
    King TE
    Am J Respir Crit Care Med; 2005 Aug; 172(3):268-79. PubMed ID: 15879420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopathic pulmonary fibrosis].
    Cordier JF
    Rev Prat; 2007 Dec; 57(20):2227-34. PubMed ID: 18320742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of lymphocytes and PIIINP with the combined pulmonary fibrosis and emphysema].
    Wei XH; Wu XY; Wang JH; Thakur A; Ma AQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):675-8. PubMed ID: 20619092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.
    Matthay MA; Zimmerman GA; Esmon C; Bhattacharya J; Coller B; Doerschuk CM; Floros J; Gimbrone MA; Hoffman E; Hubmayr RD; Leppert M; Matalon S; Munford R; Parsons P; Slutsky AS; Tracey KJ; Ward P; Gail DB; Harabin AL
    Am J Respir Crit Care Med; 2003 Apr; 167(7):1027-35. PubMed ID: 12663342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.
    Fellrath JM; du Bois RM
    Clin Exp Med; 2003 Sep; 3(2):65-83. PubMed ID: 14598183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.
    Peckham RM; Shorr AF; Helman DL
    Respiration; 2004; 71(2):165-9. PubMed ID: 15031572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future directions in sarcoidosis research: summary of an NHLBI working group.
    Martin WJ; Iannuzzi MC; Gail DB; Peavy HH
    Am J Respir Crit Care Med; 2004 Sep; 170(5):567-71. PubMed ID: 15142870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis.
    Manali ED; Stathopoulos GT; Kollintza A; Kalomenidis I; Emili JM; Sotiropoulou C; Daniil Z; Roussos C; Papiris SA
    Respir Med; 2008 Apr; 102(4):586-92. PubMed ID: 18162388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator.
    Swigris JJ; Kuschner WG; Kelsey JL; Gould MK
    Chest; 2005 Jan; 127(1):275-83. PubMed ID: 15653995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
    Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
    Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
    Pitsiou G; Papakosta D; Bouros D
    Respiration; 2011; 82(3):294-304. PubMed ID: 21677422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.